Patents by Inventor Michael C. Chen

Michael C. Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250114340
    Abstract: Disclosed herein is a method of treating interstitial lung disease and other fibrotic-mediated pulmonary diseases or disorders. The method includes administering to a subject in need thereof the deuterium-enriched pirfenidone LYT-100 at a total daily dose from about 825 mg to about 2475 mg.
    Type: Application
    Filed: December 16, 2024
    Publication date: April 10, 2025
    Inventors: Michael C. Chen, Eric Elenko, Camilla S. Graham, Varun Garg
  • Publication number: 20250114341
    Abstract: Disclosed herein is a method of treating Idiopathic Pulmonary Fibrosis (IPF). The method includes administering to a subject in need thereof the deuterium-enriched pirfenidonc LYT-100 at a total daily dose from about 1650 mg to about 2500 mg.
    Type: Application
    Filed: December 16, 2024
    Publication date: April 10, 2025
    Inventors: Michael C. Chen, Eric Elenko, Heather A. Paden, Christopher C. Korth, Paul Andrew Ford, Julie S. Krop, Camilla S. Graham, Liza C. Micioni, Simon John Hatch, Varun Garg
  • Publication number: 20250025450
    Abstract: Disclosed herein is a method of treating interstitial lung disease and other fibrotic-mediated pulmonary diseases or disorders. The method includes administering to a subject in need thereof the deuterium-enriched pirfenidone LYT-100 at a total daily dose from about 825 mg to about 2475 mg.
    Type: Application
    Filed: September 27, 2024
    Publication date: January 23, 2025
    Inventors: Michael C. Chen, Eric Elenko, Camilla S. Graham, Varun Garg
  • Publication number: 20240358690
    Abstract: Disclosed herein is a method of treating Idiopathic Pulmonary Fibrosis (IPF). The method includes administering to a subject in need thereof the deuterium-enriched pirfenidone LYT-100 at a total daily dose from about 1650 mg to about 2500 mg.
    Type: Application
    Filed: June 28, 2024
    Publication date: October 31, 2024
    Inventors: Michael C. Chen, Eric Elenko, Heather A. Paden, Christopher C. Korth, Paul Andrew Ford, Julie S. Krop, Camilla S. Graham, Liza C. Micioni, Simon John Hatch, Varun Garg
  • Publication number: 20240301458
    Abstract: The invention relates to the use of a modified terminal transferase enzyme in a method of adding one or more nucleotides to the 3? end of a nucleic acid. The invention also relates to methods of nucleic acid synthesis and sequencing comprising the use of said modified terminal transferase enzyme, to kits comprising said modified terminal transferase enzyme and to the use of said kits in methods of nucleic acid synthesis and sequencing.
    Type: Application
    Filed: April 8, 2024
    Publication date: September 12, 2024
    Inventors: Michael C. CHEN, Jiahao HUANG, Gordon MCINROY
  • Publication number: 20240084350
    Abstract: The invention relates to the use of specific terminal deoxynucleotidyl transferase (TdT) enzymes in a method of nucleic acid synthesis, to methods of synthesizing nucleic acids, and to the use of kits comprising said enzymes in a method of nucleic acid synthesis. The invention also relates to the use of terminal deoxynucleotidyl transferases and 3?-blocked nucleotide triphosphates in a method of template independent nucleic acid synthesis.
    Type: Application
    Filed: September 21, 2023
    Publication date: March 14, 2024
    Applicant: Nuclera Ltd.
    Inventors: Michael C. Chen, Radu A. Lazar, Jiahao Hung, Gordon R. Mclnroy
  • Patent number: 11807887
    Abstract: The invention relates to the use of specific terminal deoxynucleotidyl transferase (TdT) enzymes in a method of nucleic acid synthesis, to methods of synthesizing nucleic acids, and to the use of kits comprising said enzymes in a method of nucleic acid synthesis. The invention also relates to the use of terminal deoxynucleotidyl transferases and 3?-blocked nucleotide triphosphates in a method of template independent nucleic acid synthesis.
    Type: Grant
    Filed: December 17, 2021
    Date of Patent: November 7, 2023
    Assignee: Nuclera, Ltd.
    Inventors: Michael C. Chen, Radu A. Lazar, Jiahao Huang, Gordon R. McInroy
  • Publication number: 20230255946
    Abstract: Disclosed herein are methods of treating a fibrotic-mediated disorder or a collagen-mediated disorder, that include administering to a subject in need thereof a high dose of deupirfenidone, e.g., a total daily dose of up to 2500 mg. Also disclosed are interventional dosing for functionally impairing diseases and dosing for chronic disease.
    Type: Application
    Filed: January 4, 2023
    Publication date: August 17, 2023
    Applicant: Pure Tech LYT 100, Inc.
    Inventors: Eric Elenko, Michael C. Chen
  • Publication number: 20230129866
    Abstract: Disclosed herein is a method of treating a viral, e.g., SARS-CoV-2, respiratory disease or infection, such as COVID-19 related pneumonia, that includes administering deuterium-enriched pirfenidone, e.g., daily for 3 months or more, such that the viral respiratory disease or infection is treated. The treating is effective in preventing the development of, halting the progression of, or slowing the progression of one or more of pulmonary fibrosis, respiratory complications of the viral respiratory disease or infection, respiratory symptoms of the viral respiratory disease or infection or pulmonary dysfunction.
    Type: Application
    Filed: March 15, 2021
    Publication date: April 27, 2023
    Inventors: Michael C. Chen, Eric Elenko, Aleksandra Filipovic, LuAnn Sabounjian
  • Publication number: 20230040415
    Abstract: Disclosed herein are methods of treating lymphedema that include administering a clinically effective amount of deupirfenidone.
    Type: Application
    Filed: September 14, 2022
    Publication date: February 9, 2023
    Inventors: Eric Elenko, Michael C. Chen, LuAnn Sabounjian
  • Patent number: 11505815
    Abstract: The invention relates to the use of an amine masked moiety in a method of enzymatic nucleic acid synthesis. The invention also relates to said amine masked moieties per se and a process for preparing nucleotide triphosphates comprising said amine masked moieties.
    Type: Grant
    Filed: November 14, 2018
    Date of Patent: November 22, 2022
    Assignee: Nuclera Nucleics, Ltd.
    Inventors: Michael C. Chen, Gordon R. McInroy
  • Publication number: 20220112534
    Abstract: The invention relates to the use of specific terminal deoxynucleotidyl transferase (TdT) enzymes in a method of nucleic acid synthesis, to methods of synthesizing nucleic acids, and to the use of kits comprising said enzymes in a method of nucleic acid synthesis. The invention also relates to the use of terminal deoxynucleotidyl transferases and 3?-blocked nucleotide triphosphates in a method of template independent nucleic acid synthesis.
    Type: Application
    Filed: December 17, 2021
    Publication date: April 14, 2022
    Applicant: Nuclera Nucleics Ltd.
    Inventors: Michael C. Chen, Radu A. Lazar, Jiahao Huang, Gordon R. McInroy
  • Patent number: 11236377
    Abstract: The invention relates to the use of specific terminal deoxynucleotidyl transferase (TdT) enzymes in a method of nucleic acid synthesis, to methods of synthesizing nucleic acids, and to the use of kits comprising said enzymes in a method of nucleic acid synthesis. The invention also relates to the use of terminal deoxynucleotidyl transferases and 3?-blocked nucleotide triphosphates in a method of template independent nucleic acid synthesis.
    Type: Grant
    Filed: July 8, 2020
    Date of Patent: February 1, 2022
    Assignee: Nuclera Nucleics Ltd.
    Inventors: Michael C. Chen, Radu A. Lazar, Jiahao Huang, Gordon R. McInroy
  • Publication number: 20210261998
    Abstract: The invention relates to a method of nucleic acid synthesis comprising the use of 3?-O-azidomethyl blocked nucleotide triphosphates which comprises the step of adding a capping group to any uncleaved 3?-O-azidomethyl groups and to the use of kits comprising said capping groups in a method of nucleic acid synthesis. The invention also relates to capped nucleotide triphosphates and 3?-O-azidomethyl capping groups.
    Type: Application
    Filed: February 16, 2021
    Publication date: August 26, 2021
    Applicant: Nuclera Nucleics Ltd.
    Inventors: Michael C. Chen, Radu A. Lazar, Jiahao Huang, Gordon R. McInroy
  • Publication number: 20210205283
    Abstract: Disclosed herein are deuterium-enriched N-Aryl pyridinone compounds, optionally in combination with one or more additional therapeutic agents, pharmaceutical compositions comprising the same, methods of preparation thereof, and methods of use thereof. Such compounds and compositions are useful, for example, in treating diseases, disorders, or conditions such as edema.
    Type: Application
    Filed: January 7, 2021
    Publication date: July 8, 2021
    Applicant: PureTech LYT 100, Inc.
    Inventors: Eric Elenko, Michael C. Chen, LuAnn Sabounjian
  • Publication number: 20200332333
    Abstract: The invention relates to the use of specific terminal deoxynucleotidyl transferase (TdT) enzymes in a method of nucleic acid synthesis, to methods of synthesizing nucleic acids, and to the use of kits comprising said enzymes in a method of nucleic acid synthesis. The invention also relates to the use of terminal deoxynucleotidyl transferases and 3?-blocked nucleotide triphosphates in a method of template independent nucleic acid synthesis.
    Type: Application
    Filed: July 8, 2020
    Publication date: October 22, 2020
    Applicant: Nuclera Nucleics Ltd.
    Inventors: Michael C. Chen, Radu A. Lazar, Jiahao Huang, Gordon R. McInroy
  • Patent number: 10745727
    Abstract: The invention relates to the use of specific terminal deoxynucleotidyl transferase (TdT) enzymes in a method of nucleic acid synthesis, to methods of synthesizing nucleic acids, and to the use of kits comprising said enzymes in a method of nucleic acid synthesis. The invention also relates to the use of terminal deoxynucleotidyl transferases and 3?-blocked nucleotide triphosphates in a method of template independent nucleic acid synthesis.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: August 18, 2020
    Assignee: Nuclera Nucleics Ltd.
    Inventors: Michael C. Chen, Radu A. Lazar, Jiahao Huang, Gordon R. McInroy
  • Publication number: 20200093810
    Abstract: Disclosed herein are deuterium-enriched N-Aryl pyridinone compounds, optionally in combination with one or more additional therapeutic agents, pharmaceutical compositions comprising the same, methods of preparation thereof, and methods of use thereof. Such compounds and compositions are useful, for example, in treating diseases, disorders, or conditions such as edema.
    Type: Application
    Filed: September 16, 2019
    Publication date: March 26, 2020
    Inventors: Eric Elenko, Michael C. Chen, LuAnn Sabounjian
  • Patent number: 10548534
    Abstract: This application provides a system for classifying a status of anhedonia, the system including an audio data collector adapted to collect a sample of speech, and a processing module including an audio feature extractor and a classification unit, wherein the audio feature extractor extracts a plurality of acoustic features from the sample of speech, and the classification unit classifies a status of anhedonia from the plurality of acoustic features.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: February 4, 2020
    Assignee: Sonde Health Inc.
    Inventors: Michael C. Chen, Richard K. Jordan
  • Publication number: 20190144905
    Abstract: The invention relates to the use of an amine masked moiety in a method of enzymatic nucleic acid synthesis. The invention also relates to said amine masked moieties per se and a process for preparing nucleotide triphosphates comprising said amine masked moieties.
    Type: Application
    Filed: November 14, 2018
    Publication date: May 16, 2019
    Applicant: Nuclera Nucleics Ltd.
    Inventors: Michael C. Chen, Gordon R. McInroy